Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation

Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The

Read more